Viavi initiated with a Neutral at UBS

UBS initiated coverage of Viavi (VIAV) with a Neutral rating and $10.60 price target Viavi is a leader in the test, monitoring, and assurance markets for communication networks with a smaller optical security business, the analyst tells investors in a research note. The firm says that while the company is approaching a revenue inflection, it is not expecting a strong rebound.